Prospect of extracellular vesicles in tumor immunotherapy
Extracellular vesicles (EVs), as cell-derived small vesicles, facilitate intercellular communication within the tumor microenvironment (TME) by transporting biomolecules. EVs from different sources have varied contents, demonstrating differentiated functions that can either promote or inhibit cancer...
Saved in:
| Main Authors: | Wenbo Xia, Yunhan Tan, Yongen Liu, Na Xie, Huili Zhu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1525052/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Extracellular vesicles as biomarkers and drug delivery systems for tumor
by: Xue Wang, et al.
Published: (2025-07-01) -
STING Agonist Drug Delivery by Bacterial Extracellular Vesicles Induces Synergistic Immuno‐Oncology Responses and Efficient Inhibition of Tumour Growth
by: Jan Lötvall, et al.
Published: (2025-07-01) -
M1 macrophage-engineered vesicles have anti-cancer activity in ovarian cancer
by: Connie D. Cao, et al.
Published: (2025-07-01) -
Extracellular vesicles as nature's nano carriers in cancer therapy: Insights toward preclinical studies and clinical applications
by: Xiaotong Wu, et al.
Published: (2025-07-01) -
Milk-derived extracellular vesicles: nature’s nanocarriers for drug delivery and therapeutics
by: Chen Kong, et al.
Published: (2025-08-01)